Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Short term Debt (2025)

Ekso Bionics Holdings (EKSO) has disclosed Short term Debt for 2 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short term Debt changed N/A to $2.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 million, a N/A change, with the full-year FY2025 number at $2.0 million, changed N/A from a year prior.
  • Short term Debt was $2.0 million for Q4 2025 at Ekso Bionics Holdings, up from $1.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.0 million in Q4 2025 to a low of $1.9 million in Q3 2025.